Oxford Bioscience Partners
222 Berkeley Street, Suite 1650
Boston, MA 02116
Oxford Bioscience Partners (OBP) is a life science venture capital firm that provides equity financing and management assistance to start-up and early-stage, entrepreneurial-driven companies in the bioscience and healthcare industries. The General Partners of OBP currently manage venture funds with committed capital of more than $800 million.
HealthCare Ventures
55 Cambridge Parkway, Suite 301
Cambridge, MA 02142
HealthCare Ventures (HCV) is one of the world's largest venture capital firms specializing in health care, making investments in early stage and emerging growth companies that have the potential for exceptional growth. The firm has successfully raised and managed seven funds in the past nineteen years.
HLM Venture Partners
222 Berkeley Street, 21st Floor
Boston, MA 02116
HLM provides venture capital to emerging companies focused on health
care information technology, health care services, and medical
technology. Our partners offer invaluable support to entrepreneurs as
they turn innovative ideas into market-leading businesses. We assist our
portfolio companies in innumerable ways based on our extensive domain
knowledge, years of investment experience building companies and
unparalleled capital markets expertise.
New Science Ventures (NSV)
645 Madison Avenue, 20th Floor
New York, NY 10022
NSV is a New York-based venture capital firm which invests in both early and
late stage companies using novel scientific approaches to address significant
unmet needs and create order of magnitude improvements in performance. NSV
manages over $125 million and has invested in more than 20 companies located in
the US, Europe, India and China in the life sciences and information technology
sectors.
LSP BioVentures
25 First Street, Suite 300
Cambridge, MA 02141
LSP BioVentures is a US based life science fund which was launched in June 2006. The fund invests primarily in early to mid-stage product and platform companies covering a variety of sectors including: agriculture, food & nutrition, health & wellness, Cleantech and platform technologies. LSP BioVentures is the fourth fund under the LSP Group.
LSP Group provides private equity financing to early- to mid-stage life-science companies in Europe and the US. With over $500 million under management and offices in Amsterdam, Munich and Boston, LSP has over two decades of experience as specialist life-science investors.